Treatment
| |
Day of treatment or re-infestation
|
---|
|
0
|
14
|
28
|
42
|
58
|
76
|
90
|
---|
Placebo
|
Range
|
19–31
|
3–18
|
8–21
|
7–37
|
10–32
|
6–26
|
8–21
|
A. mean
|
24.6
|
10.8
|
13.1
|
17.4
|
19.8
|
14.9
|
16.5
|
G. mean1
|
24.4a
|
9.4a
|
12.6a
|
15.5a
|
18.7a
|
13.4a
|
15.7a
|
Sarolaner
|
Range
|
0–7
|
0–2
|
0–10
|
0–10
|
2–14
|
0–5
|
0–9
|
A. mean
|
0.9
|
1.0
|
3.6
|
2.8
|
6.1
|
1.1
|
2.6
|
Efficacy (%)
|
96.4
|
90.7
|
72.4
|
84.2
|
69.0
|
92.4
|
84.1
|
G. mean1
|
0.3b
|
0.8b
|
2.1b
|
1.3b
|
5.4b
|
0.8b
|
1.7b
|
Efficacy (%)
|
98.8
|
91.6
|
83.1
|
91.6
|
71.3
|
94.3
|
89.4
|
P-value vs placebo
|
< 0.0001
|
< 0.0001
|
< 0.0001
|
< 0.0001
|
< 0.0001
|
< 0.0001
|
< 0.0001
|
Fluralaner
|
Range
|
0–4
|
0–9
|
0–11
|
6–32
|
13–24
|
7–18
|
7–26
|
A. mean
|
0.9
|
2.6
|
3.4
|
19.1
|
16.9
|
11.6
|
15.9
|
Efficacy (%)
|
96.4
|
75.6
|
74.3
|
0.0
|
14.6
|
21.8
|
3.8
|
G. mean1
|
0.5b
|
1.4b
|
2.2b
|
17.4a
|
16.6a
|
11.2a
|
14.8a
|
Efficacy (%)
|
97.8
|
85.2
|
82.4
|
0.0
|
11.5
|
16.8
|
5.8
|
P-value vs placebo
|
< 0.0001
|
< 0.0001
|
< 0.0001
|
0.6487
|
0.6360
|
0.4870
|
0.8182
|
P-value vs sarolaner
|
0.5715
|
0.3246
|
0.9247
|
< 0.0001
|
0.0006
|
< 0.0001
|
< 0.0001
|
-
1Geometric means within columns with the same superscript are not significantly different (P > 0.05)